부산대학교 도서관

Diffuse malignant peritoneal mesothelioma (DMPM) is a rare and rapidly lethal tumor, poorly responsive to conventional treatments. In this regards, the identification of molecular alterations underlying DMPM onset and progression might be exploited to develop novel therapeutic strategies. Here, we focused on miR-550a-3p, which we found downregulated in 45 DMPM clinical samples compared to normal tissues and whose expression levels were associated with patient outcome. Through a gain-of-function approach using miRNA mimics in 3 DMPM cell lines, we demonstrated the tumor-suppressive role of miR-550a-3p. Specifically, miRNA ectopic expression impaired cell proliferation and invasiveness, enhanced the apoptotic response, and reduced the growth of DMPM xenografts in mice. Antiproliferative and proapoptotic effects were also observed in prostate and ovarian cancer cell lines following miR-550a-3pectopic expression. miR-550a-3peffects were mediated, at least in part, by the direct inhibition of HSP90AA1and the consequent downregulation of its target proteins, the levels of which were rescued upon disruption of miRNA-HSP90AA1mRNA pairing, partially abrogating miR-550a-3p-induced cellular effects. Our results show that miR-550a-3preconstitution affects several tumor traits, thus suggesting this approach as a potential novel therapeutic strategy for DMPM.